Mozobil

In the US, Mozobil (plerixafor systemic) is a member of the following drug classes: hematopoietic stem cell mobilizer, other immunostimulants and is used to treat Multiple Myeloma and Non-Hodgkin's Lymphoma.

US matches:

• Mozobil

UK matches:

• Mozobil 20 mg/ml solution for injection.
• Mozobil 20 mg/ml solution for injection. (SPC)

Ingredient matches for Mozobil

Plerixafor

Plerixafor is reported as an ingredient of Mozobil in the following countries:

• France


• Germany


• Greece


• Sweden


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.